Microfluidic device having offset, high-shear seeding channels
US-10836987-B2 · Nov 17, 2020 · US
US2021214670A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2021214670-A1 |
| Application number | US-202117160617-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 28, 2021 |
| Priority date | Dec 4, 2015 |
| Publication date | Jul 15, 2021 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
Opening claim text (preview).
1 - 30 . (canceled) 31 . A microfluidic device, comprising i) an open-top cavity, said cavity comprising ii) a gel matrix secured by structural anchors on the vertical wall surfaces, said gel matrix positioned above iii) a porous membrane, said membrane positioned above one or more iv) microfluidic channels. 32 . The microfluidic device of claim 31 , wherein fibroblasts are within the gel matrix and keratinocytes are on top of the gel matrix. 33 . The microfluidic device of claim 32 , wherein the keratinocytes comprise more than one layer on top of the gel matrix. 34 . The microfluidic device of claim 31 , wherein a layer of endothelial cells is positioned on the bottom of the membrane so as to be in contact with the microfluidic channels. 35 . The microfluidic device of claim 31 , wherein said cavity is circular. 36 . The microfluidic device of claim 31 , further comprising a removable cover. 37 . A microfluidic device comprising i) an open-top cavity, said cavity comprising ii) a gel matrix secured by structural anchors on the vertical wall surfaces comprising at least one of neurons and astrocytes, said gel matrix positioned above iii) a porous membrane, said membrane comprising brain microvascular endothelial cells in contact with iv) microfluidic channels. 38 . The microfluidic device of claim 37 , wherein neurons are on, in or under Ihe gel matrix. 39 . The microfluidic device of claim 37 , wherein astrocytes are on, in or under the gel matrix.
for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
with means providing thin layers · CPC title
by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip · CPC title
Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.